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Introduction.Carcinoidtumorsarelow-gradetumorsoriginatingfromendodermandmostlyinvolvingthegastrointestinalsystem.
However; they may be seen in any site within the gastrointestinal system. Case Presentation. A 69-year-old female patient. The
results of blood tests were observed to be consistent with obstructive jaundice. A mass appearance was not encountered on
tomographic examination. Papilla that was tumor-like macroscopically was seen in the second part of the duodenum in diagnostic
endoscopy. Pylorus—preserving pancreaticoduodenectomy surgical procedure was applied. On pathological examination of the
mass, a tumoral mass was detected in ampulla vateri localization, 1.5 × 1 × 0.8cm in size, which, in immunohistochemical
staining, was evaluated as a neuroendocrine tumor. Also, Metastasis was observed. Conclusion. The rarest type of carcinoid tumor
is ampullary located carcinoid tumor, and tumor size is not a reliable indicator for tumor aggressivity in ampullary carcinoid
tumors.
1.Introduction
Carcinoid tumors are low-grade tumors originating from
endoderm and mostly the involving gastrointestinal system.
Although they may be seen at any site in the whole
gastrointestinal system, the most commonly involved areas
areappendix,distalsmallintestine,rectum,andstomach[1].
Herein, we described the rarest type of carcinoid tumor.
2.CaseReport
A 69-year-old female patient was examined as jaundice
was added to abdominal pain, accompanied by intermittent
emesis and vomiting, lasting for 3 months. Results of
blood tests were observed to be consistent with obstructive
jaundice. A mass appearance was not encountered on
tomographic examination obtained with prediagnosis of
pancreatic cancer due to hydropic gallbladder and choledoc
dilation on abdominal ultrasonography (Figure 1). Papilla
that was tumor-like macroscopically was seen in the second
part of the duodenum in diagnostic endoscopy (Figure 2).
Thepatient, whoseendoscopic biopsy resultwasevaluatedas
a well-diﬀerentiated endocrine tumor, was operated on. An
ovoid mass 2 × 2cm in size was detected in ampulla vateri
in intra-abdominal exploration. Pylorus—preserving pan-
creaticoduodenectomy surgical procedure was applied to the
patient as the mass did not make vascular invasion but local
invasion.Thepatientinwhomamajorsurgicalcomplication
was not observed in postoperative followup was discharged
in the postoperative second week. On pathologic examina-
tion of the mass, a tumoral mass was detected in ampulla
vateri localization, 1.5 × 1 × 0.8cm in size, and invaded
submucosa and muscularis propria. The patient whose
specimens were stained synaptophysin (+), chromogranin-A
(+),andKi-67 2%(+)inimmunohistochemical stainingwas
evaluated as a neuroendocrine tumor (Figure 3). Metastasis
w a so b s e r v e di no n eo u to f1 0l y m p hn o d e st h a tw e r es o r t e d
out in the peripancreatic region of the patient whose surgical
margins were healthy. No other foci were encountered in
octreotide scintigraphy in the postoperative ﬁrst month2 Case Reports in Medicine
33
Figure 1: Hydropic gallbladder and choledoc dilation were seen on
tomographic examination, Yet any mass appearance or lymph node
was not encountered.
Figure 2: Papilla that was tumor-like macroscopically was seen in
endoscopic retrograde cholangio pancreatography.
in the patient who was diagnosed as a well-diﬀerentiated
endocrins tumor on histopathologic evaluation. Adjuvant
chemotherapy and biologic treatment were not planned
because of the absence of carcinoid syndrome ﬁndings and
poor prognostic histopathologic properties.
3. Discussion
Ampullary located carcinoid tumor was ﬁrst described by
Oberndorfer in 1907 [2]. Although most of the reports are
comprisedofcasereports,approximately120caseshavebeen
reported to date. It is rarer than even duodenal involvement
deﬁned as rare (2%) with this number (0.05%) [3, 4].
Its clinical presentation is composed of jaundice (53,1%),
abdominal pain (24,6%), pancreatitis (6,0%), and weight
loss (3,6%) [1–4]. Abdominal tomography and endoscopic
Figure 3: Specimens were stained synaptophysin (+), chromo-
granin-A (+), Ki–67 2% (+) in immunohistochemical staining.
imaging methods are also valuable besides clinical ﬁndings
for making a diagnosis. Of endoscopic imaging methods,
especially endoscopic retrograde cholangio pancreatography,
endoscopic biopsy and endosonographic ultrasonography
may be used for the detection of invasion depth [5]. In 25%
of ampullary carcinoid tumors, they are seen to be related
with von Recklinghausen syndrome and MEN syndromes.
Additionally, most of the ampullary tumors have been seen
to be positive in terms of somatostatin in pathologic exami-
nation. Thus octreotide scintigraphy is used with the aim of
screening[6].Forcarcinoidtumorswithunknownmalignity
potential, a novel classiﬁcation system was developed by the
World Health Organization which classes tumors as benign,
potentially malignant and malignant. In this classiﬁcation,
tumor proliferative index, invasion depth, and anatomic
location were evaluated [7, 8]. Ampullary carcinoid tumors
stillhaveobscurities abouttheissueslikeprognostic features,
invasion depths, and lymph node metastasis because of its
prevalence [9]. These obscurities also reﬂect on surgical
treatment strategy of ampullary carcinoid tumors. Makhlouf
et al. stated that metastatic disease was not in question for
duodenal carcinoid tumors smaller than 20mm, whereas the
same may not be said for ampullary carcinoid tumors. In
literature, the presence of metastatic disease was seen in 40–
50% of ampullary carcinoid cases smaller than 20mm. Thus
it is advocated that the most appropriate surgical treatment
option should be the Whipple procedure [9, 10].
In our case, metastasis of lymph node was found
although the tumor size was below 20mm, and all signs
were not marked by the CT scan. Today, with the knowledge
gained from oncologic surgical interventions, pancreatico-
duodenectomy has become routinely practicable without
any complications, which was inconceivable in the past.
Therefore, we consider that, the most appropriate surgical
treatment option for ampullary carcinoid tumors must be
the Whipple procedure. Hwang et al. detected one-year
survey as 90% and three-year survey as 64% in 10 patients
who underwent pancreaticoduodenectomy with a mean
tumor size of 2.1 ± 1.3cm [11].Case Reports in Medicine 3
The opponent group states that lymph node dissection
does not have a therapeutic eﬀect on ampullary carcinoid
tumors and thus recommends local excision or endoscopic
resection with lower morbidity and mortality [12, 13].
However, as described by Clement et al., the possibility of
residual tumoral formation is high with local resection, just
as in the case that showed local recurrence 20 months after
local excision [14]. These ﬁndings indicate that tumor size is
not a reliable indicator for tumor aggressivity in ampullary
carcinoid tumors. Adjuvant treatment options should be
planned by taking prognostic factors of tumor and carcinoid
syndrome ﬁndings into consideration. Adjuvant chemother-
apy may be administered following resection in tumors
that have poor prognostic factors. The most commonly
used agents for chemotherapy are streptozocin, doxorubicin,
dacarbazine, and 5-ﬂuorouracil. Other treatment options
are biologic therapy (interferon INF, somatostatin analogues
SST) and chemoembolization [13, 14].
4. Conclusion
Gastrointestinal system-related deaths are placed highly
among cancer-related deaths. Hepatobiliary system cancers
are the most feared tumors among all gastrointestinal system
tumors with a prevalence of 7–300/100.00 [15]. The only
known potential therapeutic treatment option for these
cancers is surgical RO resection. The presence of lymph
node metastasis and tumor size is known as an independent
prognostic factor for hepatobiliary cancers. However, tumor
size is not a reliable indicator for tumor aggressivity in
ampullary carcinoid tumors.
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